Millbrae, CA, United States of America

Jeff Dener

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Virobay, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeff Dener. Retrieved from https://idiyas.com/inventor/jeff-dener

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeff Dener: Innovator in Pharmaceutical Chemistry

Introduction

Jeff Dener is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as cysteine protease inhibitors. His work is essential in advancing therapeutic options for various medical conditions.

Latest Patents

Jeff Dener holds 1 patent related to a process for the preparation of alkyl esters of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid. This invention is crucial as it provides intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-difluoro-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)pentanamide and related compounds.

Career Highlights

Jeff Dener is currently associated with Virobay, Inc., where he continues to innovate in the pharmaceutical sector. His expertise and dedication have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Jeff has collaborated with esteemed colleagues, including Barry Patrick Hart and Michael J Green. These partnerships have further enhanced his contributions to pharmaceutical research.

Conclusion

Jeff Dener's work exemplifies the impact of innovation in pharmaceutical chemistry. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…